{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:29:37Z","timestamp":1790990977915,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00520-021-06362-y","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T20:02:31Z","timestamp":1624046551000},"page":"7687-7694","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Oral health condition in cancer patients under bisphosphonate therapy"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6410-0551","authenticated-orcid":false,"given":"Rog\u00e9rio","family":"Jardim Caldas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1076-8019","authenticated-orcid":false,"given":"H\u00e9liton","family":"Sp\u00edndola Antunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8763-4967","authenticated-orcid":false,"given":"Camila","family":"de Oliveira Rodini Pegoraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bio","family":"Ribeiro Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0674-3759","authenticated-orcid":false,"given":"Paulo S\u00e9rgio","family":"da Silva Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,18]]},"reference":[{"key":"6362_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41413-020-0088-1","volume":"8","author":"JT Wan","year":"2020","unstructured":"Wan JT, Sheeley DM, Somerman MJ, Lee JS (2020) Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors. Bone Res 8:1\u201312. https:\/\/doi.org\/10.1038\/s41413-020-0088-1","journal-title":"Bone Res"},{"key":"6362_CR2","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/odi.13294","volume":"26","author":"O Nicolatou-Galitis","year":"2020","unstructured":"Nicolatou-Galitis O, Papadopoulou E, Vardas E, Kouri M, Galiti D, Galitis E, Alexiou KE, Tsiklakis K, Ardavanis A, Razis E, Athanasiadis I, Droufakou S, Psyrri A, Karamouzis MV, Linardou H, Daliani D, Tzanninis D, Sachanas S, Laschos K, Kyrtsonis MC, Antoniou F, Laskarakis A, Giassas S, Nikolaidi A, Rigakos G, Ntokou A, Migliorati CA, Ripamonti CI (2020) Alveolar bone histological necrosis observed prior to extractions in patients, who received bone-targeting agents. Oral Dis 26:955\u2013966. https:\/\/doi.org\/10.1111\/odi.13294","journal-title":"Oral Dis"},{"key":"6362_CR3","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O\u2019Ryan F (2014) American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw\u20142014. J Oral and Maxillofac Surg 72:1938\u20131956. https:\/\/doi.org\/10.1016\/j.joms.2014.04.031","journal-title":"J Oral and Maxillofac Surg"},{"key":"6362_CR4","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/j.joms.2018.03.007","volume":"76","author":"MQS Soares","year":"2018","unstructured":"Soares MQS, Van Dessel J, Jacobs R, da Silva Santos PS, Cestari TM, Garlet GP, Duarte MAH, Imada TSN, Lambrichts I, Rubira-Bullen IRF (2018) Zoledronic acid induces site-specific structural changes and decreases vascular area in the alveolar bone. J Oral and Maxillofac Surg 76:1893\u20131901. https:\/\/doi.org\/10.1016\/j.joms.2018.03.007","journal-title":"J Oral and Maxillofac Surg"},{"key":"6362_CR5","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1177\/0022034515572021","volume":"94","author":"H Katsarelis","year":"2015","unstructured":"Katsarelis H, Shah NP, Dhariwal DK, Pazianas M (2015) Infection and medication-related osteonecrosis of the jaw. J Dental Res 94:534\u2013539. https:\/\/doi.org\/10.1177\/0022034515572021","journal-title":"J Dental Res"},{"key":"6362_CR6","volume-title":"Oral health surveys: basic methods","author":"[WHO] WORLD HEALTH ORGANIZATION","year":"2013","unstructured":"[WHO] WORLD HEALTH ORGANIZATION (2013) Oral health surveys: basic methods. WHO, Monts"},{"key":"6362_CR7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3109\/00016356309011240","volume":"21","author":"H L\u00f6e","year":"1963","unstructured":"L\u00f6e H, Silness J (1963) Periodontal disease in pregnancy I. Prevalence and severity. Acta Odontol Scand 21:533\u2013551. https:\/\/doi.org\/10.3109\/00016356309011240","journal-title":"Acta Odontol Scand"},{"key":"6362_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.14219\/jada.archive.1964.0034","volume":"68","author":"JG Greene","year":"1964","unstructured":"Greene JG, Vermillion JR (1964) The simplified oral hygiene index. J Am Dent Assoc 68:7\u201313. https:\/\/doi.org\/10.14219\/jada.archive.1964.0034","journal-title":"J Am Dent Assoc"},{"key":"6362_CR9","doi-asserted-by":"publisher","first-page":"8580","DOI":"10.1200\/jco.2005.02.8670","volume":"23","author":"A Bamias","year":"2005","unstructured":"Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Bozas G, Koutsoukou V, Gika D, Anagnostopoulos A, Papadimitriou C, Terpos E, Dimopoulos MA (2005) Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 23:8580\u20138587. https:\/\/doi.org\/10.1200\/jco.2005.02.8670","journal-title":"J Clin Oncol"},{"key":"6362_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1056\/NEJM200507073530120","volume":"353","author":"BGM Durie","year":"2005","unstructured":"Durie BGM, Katz M, Crowley J (2005) Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 353:99\u2013102. https:\/\/doi.org\/10.1056\/NEJM200507073530120","journal-title":"N Engl J Med"},{"key":"6362_CR11","doi-asserted-by":"publisher","first-page":"968","DOI":"10.3324\/%25x","volume":"91","author":"MA Dimopoulos","year":"2006","unstructured":"Dimopoulos MA, Kastritis E, Anagnostopoulos A, Melakopoulos I, Gika D, Moulopoulos LA, Bamia C, Terpos E, Tsionos K, Bamias A (2006) Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid. Haematologica 91:968\u2013971. https:\/\/doi.org\/10.3324\/%25x","journal-title":"Haematologica"},{"key":"6362_CR12","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/j.joms.2007.03.006","volume":"65","author":"EP Wang","year":"2007","unstructured":"Wang EP, Kaban LB, Strewler GJ, Raje N, Troulis MJ (2007) Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy. J Oral and Maxillofac Surg 65:1328\u20131331. https:\/\/doi.org\/10.1016\/j.joms.2007.03.006","journal-title":"J Oral and Maxillofac Surg"},{"key":"6362_CR13","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.oraloncology.2007.11.012","volume":"44","author":"T Boonyapakorn","year":"2008","unstructured":"Boonyapakorn T, Schirmer I, Reichart PA, Sturm I, Massenkeil G (2008) Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies. Oral Oncol 44:857\u2013869. https:\/\/doi.org\/10.1016\/j.oraloncology.2007.11.012","journal-title":"Oral Oncol"},{"key":"6362_CR14","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.eururo.2008.06.070","volume":"54","author":"C Walter","year":"2008","unstructured":"Walter C, Al-Nawas B, Gr\u00f6tz KA, Thomas C, Th\u00fcroff JW, Zinser V, Gamm H, Beck J, Wagner W (2008) Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate. Eur Urol 54:1066\u20131072. https:\/\/doi.org\/10.1016\/j.eururo.2008.06.070","journal-title":"Eur Urol"},{"key":"6362_CR15","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/hed.20941","volume":"31","author":"MR Stumpe","year":"2009","unstructured":"Stumpe MR, Chandra RK, Yunus F, Samant S (2009) Incidence and risk factors of bisphosphonate-associated osteonecrosis of the jaws. Head Neck 31:202\u2013206. https:\/\/doi.org\/10.1002\/hed.20941","journal-title":"Head Neck"},{"key":"6362_CR16","doi-asserted-by":"publisher","first-page":"5356","DOI":"10.1200\/jco.2009.21.9584","volume":"27","author":"K Vahtsevanos","year":"2009","unstructured":"Vahtsevanos K, Kyrgidis A, Verrou E, Katodritou E, Triaridis S, Andreadis CG, Boukovinas I, Koloutsos GE, Teleioudis Z, Kitikidou K, Paraskevopoulos P, Zervas K, Antoniades K (2009) Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw. J Clin OncoL 27:5356\u20135362. https:\/\/doi.org\/10.1200\/jco.2009.21.9584","journal-title":"J Clin OncoL"},{"key":"6362_CR17","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1097\/JTO.0b013e31826aec2b","volume":"7","author":"GV Scagliotti","year":"2012","unstructured":"Scagliotti GV, Hirsh V, Siena S, Henry DH, Woll PJ, Manegold C, Solal-Celigny P, Rodriguez G, Krzakowski M, Mehta ND, Lipton L, Garc\u00eda-S\u00e1enz JA, Pereira JR, Prabhash K, Ciuleanu TE, Kanarev V, Wang H, Balakumaran A, Jacobs I (2012) Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study. J Thorac Oncol 7:1823\u20131829. https:\/\/doi.org\/10.1097\/JTO.0b013e31826aec2b","journal-title":"J Thorac Oncol"},{"key":"6362_CR18","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1248\/bpb.b15-00385","volume":"38","author":"M Kajizono","year":"2015","unstructured":"Kajizono M, Sada H, Sugiura Y, Soga Y, Kitamura Y, Matsuoka J, Sendo T (2015) Incidence and risk factors of osteonecrosis of the jaw in advanced cancer patients after treatment with zoledronic acid or denosumab: a retrospective cohort study. Biol Pharm Bull 38:1850\u20131855. https:\/\/doi.org\/10.1248\/bpb.b15-00385","journal-title":"Biol Pharm Bull"},{"key":"6362_CR19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.5114\/aoms.2015.50964","volume":"11","author":"M Kos","year":"2015","unstructured":"Kos M (2015) Incidence and risk predictors for osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. Arch Med Sci 11:319\u2013324. https:\/\/doi.org\/10.5114\/aoms.2015.50964","journal-title":"Arch Med Sci"},{"key":"6362_CR20","doi-asserted-by":"publisher","first-page":"e342","DOI":"10.4317\/medoral.21728","volume":"22","author":"M Manfredi","year":"2017","unstructured":"Manfredi M, Mergoni G, Goldoni M, Salvagni S, Merigo E, Meleti M, Vescovi P (2017) A 5-year retrospective longitudinal study on the incidence and the risk factors of osteonecrosis of the jaws in patients treated with zoledronic acid for bone metastases from solid tumors. Med Oral Patol Oral Cir Bucal 22:e342\u2013e348. https:\/\/doi.org\/10.4317\/medoral.21728","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"6362_CR21","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1080\/17843286.2017.1348001","volume":"73","author":"T Loyson","year":"2018","unstructured":"Loyson T, Van Cann T, Sch\u00f6ffski P, Clement PM, Bechter O, Spriet I, Coropciuc R, Politis C, Vandeweyer RO, Schoenaers J, Dumez H, Berteloot P, Neven P, Nackaerts K, Woei-A-Jin FJSH, Punie K, Wildiers H, Beuselinc B (2018) Incidence of osteonecrosis of the jaw in patients with bone metastases treated sequentially with bisphosphonates and denosumab. Acta Clin Belg 73:100\u2013109. https:\/\/doi.org\/10.1080\/17843286.2017.1348001","journal-title":"Acta Clin Belg"},{"key":"6362_CR22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.oooo.2020.04.808","volume":"130","author":"F Hallmer","year":"2020","unstructured":"Hallmer F, Bjarnadottir O, G\u00f6trick B, Malmstr\u00f6m P, Andersson G (2020) Incidence of and risk factors for medication-related osteonecrosis of the jaw in women with breast cancer with bone metastasis: a population-based study. Oral Surg Oral Med Oral Pathol Oral Radiol 130:252\u2013257. https:\/\/doi.org\/10.1016\/j.oooo.2020.04.808","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"6362_CR23","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/acel.12578","volume":"16","author":"KM Stearns-Reider","year":"2017","unstructured":"Stearns-Reider KM, D\u2019Amore A, Beezhold K, Rothrauff B, Cavalli L, Wagner WR, Vorp DA, Tsamis A, Shinde S, Zhang C, Barchowsky A, Rando TA, Tuan RS, Ambrosio F (2017) Aging of the skeletal muscle extracellular matrix drives a stem cell fibrogenic conversion. Aging Cell 16:518\u2013528. https:\/\/doi.org\/10.1111\/acel.12578","journal-title":"Aging Cell"},{"key":"6362_CR24","doi-asserted-by":"publisher","first-page":"115493","DOI":"10.1016\/j.bone.2020.115493","volume":"139","author":"MJ Rogers","year":"2020","unstructured":"Rogers MJ, M\u00f6nkk\u00f6nen J, Munoz MA (2020) Molecular mechanisms of action of bisphosphonates and new insights into their effects outside the skeleton. Bone 139:115493. https:\/\/doi.org\/10.1016\/j.bone.2020.115493","journal-title":"Bone"},{"key":"6362_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.5114\/aoms.2014.40738","volume":"10","author":"M Kos","year":"2014","unstructured":"Kos M (2014) Association of dental and periodontal status with bisphosphonate-related osteonecrosis of the jaws. A retrospective case-controlled study. Arch Med Sci 10:117\u2013123. https:\/\/doi.org\/10.5114\/aoms.2014.40738","journal-title":"Arch Med Sci"},{"key":"6362_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jpor.2014.08.001","volume":"59","author":"K Niibe","year":"2015","unstructured":"Niibe K, Ouchi T, Iwasaki R, Nakagawa T, Horie N (2015) Osteonecrosis of the jaw in patients with dental prostheses being treated with bisphosphonates or denosumab. J Prosthodont Res 59:3\u20135. https:\/\/doi.org\/10.1016\/j.jpor.2014.08.001","journal-title":"J Prosthodont Res"},{"key":"6362_CR27","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.jcms.2015.05.021","volume":"43","author":"JL Borke","year":"2015","unstructured":"Borke JL, McAllister B, Harris T, Neiberg M, Guevarra-Toth C, Fulzele S, Stoianovici C, Guerra C (2015) Correlation of changes in the mandible and retina\/choroid vasculature of a rat model of BRONJ. J Craniomaxillofac Surg 43:1144\u20131150. https:\/\/doi.org\/10.1016\/j.jcms.2015.05.021","journal-title":"J Craniomaxillofac Surg"},{"key":"6362_CR28","first-page":"237","volume":"47","author":"J Kapitola","year":"1998","unstructured":"Kapitola J, Zak J (1998) Effect of pamidronate on bone blood flow in oophorectomized rats. Physiol Res 47:237\u2013240","journal-title":"Physiol Res"},{"key":"6362_CR29","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1177\/0022034510397196","volume":"90","author":"A Barasch","year":"2011","unstructured":"Barasch A, Cunha-Cruz J, Curro FA, Hujoel P, Sung AH, Vena D, Voinea-Griffin AE, Beadnell S, Craig RG, DeRouen T, Desaranayake A, Gilbert A, Gilbert GH, Goldberg K, Hauley R, Hashimoto M, Holmes J, Latzke B, Leroux B, Lindblad A, Richman J, Safford M, Ship J, Thompson VP, Williams OD, Yin W (2011) Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRN. J Dent Res 90:439\u2013444. https:\/\/doi.org\/10.1177\/0022034510397196","journal-title":"J Dent Res"},{"key":"6362_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201343","volume":"13","author":"S Soutome","year":"2018","unstructured":"Soutome S, Hayashida S, Funahara M, Sakamoto Y, Kojima Y, Yanamoto S, Umeda M (2018) Factors affecting development of medication- related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor? PLoS ONE 13:e0201343. https:\/\/doi.org\/10.1371\/journal.pone.0201343","journal-title":"PLoS ONE"},{"key":"6362_CR31","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.ijom.2015.01.014","volume":"44","author":"M Nisi","year":"2015","unstructured":"Nisi M, La Ferla F, Karapetsa D, Gennai S, Miccoli M, Baggiani A, Graziani F, Gabriele M (2015) Risk factors influencing BRONJ staging in patients receiving intravenous bisphosphonates: a multivariate analysis. Int J Oral and Maxillofac Surg 44:586\u2013591. https:\/\/doi.org\/10.1016\/j.ijom.2015.01.014","journal-title":"Int J Oral and Maxillofac Surg"},{"key":"6362_CR32","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","volume":"23","author":"F Saad","year":"2012","unstructured":"Saad F, Brown JE, Van Poznak C, Ibrahim T, Stemmer SM, Stopeck AT, Diel IJ, Takahashi S, Shore N, Henry DH, Barrios CH, Facon T, Senecal F, Fizazi K, Zhou L, Daniels A, Carri\u00e8re P, Dansey R (2012) Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Ann Oncol 23:1341\u20131347. https:\/\/doi.org\/10.1093\/annonc\/mdr435","journal-title":"Ann Oncol"},{"key":"6362_CR33","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1016\/j.tripleo.2008.07.011","volume":"106","author":"D Carmagnola","year":"2008","unstructured":"Carmagnola D, Celestino S, Abati S (2008) Dental and periodontal history of oncologic patients on parenteral bisphosphonates with or without osteonecrosis of the jaws: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol 106:e10\u2013e15. https:\/\/doi.org\/10.1016\/j.tripleo.2008.07.011","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"6362_CR34","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.oooo.2012.05.017","volume":"115","author":"AL Watters","year":"2013","unstructured":"Watters AL, Hansen HJ, Williams T, Chou JF, Riedel E, Halpern J, Tunick S, Bohle G, Huryn JM, Estilo CL (2013) Intravenous bisphosphonate-related osteonecrosis of the jaw: long-term follow-up of 109 patients. Oral Surg Oral Med Oral Pathol Oral Radiol 115:192\u2013200. https:\/\/doi.org\/10.1016\/j.oooo.2012.05.017","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"6362_CR35","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1080\/10428194.2017.1300889","volume":"58","author":"E Kastritis","year":"2017","unstructured":"Kastritis E, Melea P, Bagratuni T, Melakopoulos I, Gavriatopoulou M, Roussou M, Migkou M, Eleutherakis-Papaiakovou E, Terpos E, Dimopoulos MA (2017) Genetic factors related with early onset of osteonecrosis of the jaw in patients with multiple myeloma under zoledronic acid therapy. Leuk Lymphoma 58:2304\u20132309. https:\/\/doi.org\/10.1080\/10428194.2017.1300889","journal-title":"Leuk Lymphoma"},{"key":"6362_CR36","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10006-013-0408-3","volume":"18","author":"M Krimmel","year":"2014","unstructured":"Krimmel M, Ripperger J, Hairass M, Hoefert S, Kluba S, Reinert S (2014) Does dental and oral health influence the development and course of bisphosphonate-related osteonecrosis of the jaws (BRONJ)? Oral Maxillofac Surg 18:213\u2013218. https:\/\/doi.org\/10.1007\/s10006-013-0408-3","journal-title":"Oral Maxillofac Surg"},{"key":"6362_CR37","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.jcms.2017.07.002","volume":"45","author":"S Otto","year":"2017","unstructured":"Otto S, Pautke C, Martin Jurado O, Nehrbass D, Stoddart MJ, Ehrenfeld M, Zeiter S (2017) Further development of the MRONJ minipig large animal model. J Craniomaxillofac Surg 45:1503\u20131514. https:\/\/doi.org\/10.1016\/j.jcms.2017.07.002","journal-title":"J Craniomaxillofac Surg"},{"key":"6362_CR38","doi-asserted-by":"publisher","first-page":"e285","DOI":"10.4317\/jced.56265","volume":"12","author":"G Simpione","year":"2020","unstructured":"Simpione G, Caldas RJ, Soares MQS, Rubira-Bullen IRF, Santos PSS (2020) Tomographic study of jaw bone changes in patients with bisphosphonate-related osteonecrosis. J Clin Exp Dent 12:e285\u2013e290. https:\/\/doi.org\/10.4317\/jced.56265","journal-title":"J Clin Exp Dent"},{"key":"6362_CR39","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/annonc\/mdn554","volume":"20","author":"MA Dimopoulos","year":"2009","unstructured":"Dimopoulos MA, Kastritis E, Bamia C, Melakopoulos I, Gika D, Roussou M, Migkou M, Eleftherakis-Papaiakovou E, Christoulas D, Terpos E, Bamias A (2009) Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid. Ann Oncol 20:117\u2013120. https:\/\/doi.org\/10.1093\/annonc\/mdn554","journal-title":"Ann Oncol"},{"key":"6362_CR40","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.oooo.2018.02.003","volume":"125","author":"AA Owosho","year":"2018","unstructured":"Owosho AA, Liang STY, Sax AZ, Wu K, Yom SK, Huryn JM, Estilo CL (2018) Medication-related osteonecrosis of the jaw: an update on the Memorial Sloan Kettering Cancer Center experience and the role of premedication dental evaluation in prevention. Oral Surg Oral Med Oral Pathol Oral Radiol 125:440\u2013445. https:\/\/doi.org\/10.1016\/j.oooo.2018.02.003","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-021-06362-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-021-06362-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-021-06362-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T12:28:37Z","timestamp":1635251317000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-021-06362-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,18]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6362"],"URL":"https:\/\/doi.org\/10.1007\/s00520-021-06362-y","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,18]]},"assertion":[{"value":"17 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This multicenter study was conducted in accordance with the ethical principles of the World Medical Association and 1964 Helsinki Declaration and was approved by the Research Ethics Committee of the involved\u00a0institutions by registration number CAEE44723715.7.1001.527.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All research participants received detailed explanations with appropriate language to their comprehension and freely decided to participate in the research, signing the informed consent form. The procedures used on all participants were performed after obtaining the signed consent form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"N\/A","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The first author received a scholarship from CAPES during the research period. The other authors declare that they have no conflict of interest with respect to the authorship and\/or publication of this article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}